Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 19, 2022

BUY
$118.07 - $194.18 $3,542 - $5,825
30 New
30 $3,000
Q2 2022

Jul 12, 2022

SELL
$117.13 - $176.59 $6,559 - $9,889
-56 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$126.46 - $235.05 $7,081 - $13,162
56 New
56 $9,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.